Nexalin (NXL) Revenue & Revenue Breakdown
Nexalin Revenue Highlights
Latest Revenue (Y)
$110.75K
Latest Revenue (Q)
$26.84K
Main Segment (Y)
Licensing Fee
Main Geography (Y)
UNITED STATES
Nexalin Revenue by Period
Nexalin Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $110.75K | -91.62% |
| 2022-12-31 | $1.32M | 817.20% |
| 2021-12-31 | $144.06K | -40.69% |
| 2020-12-31 | $242.91K | 17.13% |
| 2019-12-31 | $207.38K | - |
Nexalin generated $110.75K in revenue during NA 2023, up -91.62% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Nexalin Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $26.84K | -65.88% |
| 2024-03-31 | $78.67K | 283.09% |
| 2023-12-31 | $20.54K | -14.83% |
| 2023-09-30 | $24.11K | -32.15% |
| 2023-06-30 | $35.54K | 16.30% |
| 2023-03-31 | $30.56K | -20.47% |
| 2022-12-31 | $38.42K | -92.95% |
| 2022-09-30 | $545.32K | 31.63% |
| 2022-06-30 | $414.29K | 28.13% |
| 2022-03-31 | $323.32K | 1247.23% |
| 2021-12-31 | $24.00K | -57.12% |
| 2021-09-30 | $55.97K | 91.99% |
| 2021-06-30 | $29.15K | -16.57% |
| 2021-03-31 | $34.94K | 7.51% |
| 2020-12-31 | $32.50K | -11.93% |
| 2020-09-30 | $36.91K | -57.46% |
| 2020-06-30 | $86.75K | -0.00% |
| 2020-03-31 | $86.75K | - |
Nexalin generated $26.84K in revenue during Q2 2024, up -65.88% compared to the previous quarter, and up 87.83% compared to the same period a year ago.
Nexalin Revenue Breakdown
Nexalin Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 |
|---|---|---|
| Other | $1.37K | $26.41K |
| Equipment | $27.30K | $26.78K |
| Licensing Fee | $82.08K | $79.19K |
| Device Sales | - | $1.16M |
Nexalin's latest annual revenue breakdown by segment (product or service), as of Dec 23: Licensing Fee (74.11%), Equipment (24.65%), and Other (1.24%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 |
|---|---|---|---|---|---|---|---|
| Licensing Fee | $21.56K | $19.51K | $18.66K | $20.03K | $23.87K | $18.63K | $21.11K |
| Equipment | $1.51K | $10.62K | $5.18K | $5.10K | $6.40K | $4.75K | $4.10K |
| Other | $100.00 | $2.00 | $270.00 | $807.00 | $290.00 | $275.00 | $110.00 |
| Device Sales | $55.50K | $9.60K | - | $520.00K | - | - | - |
Nexalin's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Device Sales (70.55%), Licensing Fee (27.40%), Equipment (1.92%), and Other (0.13%).
Nexalin Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 |
|---|---|---|
| UNITED STATES | $107.13K | $113.54K |
| CHINA | $3.61K | $1.21M |
Nexalin's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (96.74%), and CHINA (3.26%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | $23.17K | $27.13K | $24.11K | $25.33K | $30.56K | $23.68K | $25.32K |
| CHINA | - | - | $10.21K | $14.75K | $520.00K | - | - |
Nexalin's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (100.00%).
Nexalin Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.60M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| IRIX | IRIDEX | $51.87M | $12.63M |
| AZYO | Elutia | $49.19M | $6.13M |
| LNSR | LENSAR | $42.16M | $10.59M |
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| OSA | ProSomnus | $27.65M | $7.46M |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| MOTS | Motus GI | $319.00K | $64.00K |
| AIMD | Ainos | $122.11K | - |
| NXL | Nexalin | $110.75K | $26.84K |
| BJDX | Bluejay Diagnostics | - | - |
| MODD | Modular Medical | - | - |
NXL Revenue FAQ
What is Nexalin’s yearly revenue?
Nexalin's yearly revenue for 2023 was $110.75K, representing a decrease of -91.62% compared to 2022. The company's yearly revenue for 2022 was $1.32M, representing an increase of 817.20% compared to 2021. NXL's yearly revenue for 2021 was $144.06K, representing a decrease of -40.69% compared to 2020.
What is Nexalin’s quarterly revenue?
Nexalin's quarterly revenue for Q2 2024 was $26.84K, a -65.88% decrease from the previous quarter (Q1 2024), and a -24.48% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $78.67K, a 283.09% increase from the previous quarter (Q4 2023), and a 157.43% increase year-over-year (Q1 2023). NXL's quarterly revenue for Q4 2023 was $20.54K, a -14.83% decrease from the previous quarter (Q3 2023), and a -46.55% decrease year-over-year (Q4 2022).
What is Nexalin’s revenue growth rate?
Nexalin's revenue growth rate for the last 3 years (2021-2023) was -23.13%, and for the last 5 years (2019-2023) was -46.60%.
What are Nexalin’s revenue streams?
Nexalin's revenue streams in c 23 are Other, Equipment, and Licensing Fee. Other generated $1.37K in revenue, accounting 1.24% of the company's total revenue, down -94.82% year-over-year. Equipment generated $27.3K in revenue, accounting 24.65% of the company's total revenue, up 1.95% year-over-year. Licensing Fee generated $82.08K in revenue, accounting 74.11% of the company's total revenue, up 3.65% year-over-year.
What is Nexalin’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Nexalin was Licensing Fee. This segment made a revenue of $82.08K, representing 74.11% of the company's total revenue.